nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefaclor—MPO—Crohn's disease	0.47	1	CbGaD
Cefaclor—MPO—Mesalazine—Crohn's disease	0.386	1	CbGbCtD
Cefaclor—MPO—superior mesenteric artery—Crohn's disease	0.0375	0.748	CbGeAlD
Cefaclor—Bilirubin total increased—Mesalazine—Crohn's disease	0.00267	0.0373	CcSEcCtD
Cefaclor—Potassium increased—Prednisone—Crohn's disease	0.00209	0.0292	CcSEcCtD
Cefaclor—MPO—IL23-mediated signaling events—IL23R—Crohn's disease	0.00187	0.107	CbGpPWpGaD
Cefaclor—SLC15A2—mouth—Crohn's disease	0.00181	0.0362	CbGeAlD
Cefaclor—MPO—IL23-mediated signaling events—IL18RAP—Crohn's disease	0.00178	0.102	CbGpPWpGaD
Cefaclor—SLC15A1—epithelium—Crohn's disease	0.00169	0.0337	CbGeAlD
Cefaclor—MPO—IL23-mediated signaling events—IL23A—Crohn's disease	0.00159	0.0913	CbGpPWpGaD
Cefaclor—MPO—epithelium—Crohn's disease	0.00152	0.0303	CbGeAlD
Cefaclor—SLC15A1—mammalian vulva—Crohn's disease	0.00146	0.0292	CbGeAlD
Cefaclor—MPO—skin of body—Crohn's disease	0.00144	0.0288	CbGeAlD
Cefaclor—Cholestasis—Mercaptopurine—Crohn's disease	0.0013	0.0181	CcSEcCtD
Cefaclor—SLC15A1—digestive system—Crohn's disease	0.00128	0.0256	CbGeAlD
Cefaclor—Pruritus genital—Mesalazine—Crohn's disease	0.00128	0.0179	CcSEcCtD
Cefaclor—MPO—lymphoid tissue—Crohn's disease	0.00117	0.0233	CbGeAlD
Cefaclor—MPO—digestive system—Crohn's disease	0.00116	0.0231	CbGeAlD
Cefaclor—Nephropathy—Mesalazine—Crohn's disease	0.00113	0.0157	CcSEcCtD
Cefaclor—Vaginal moniliasis—Mesalazine—Crohn's disease	0.00106	0.0148	CcSEcCtD
Cefaclor—Lactic dehydrogenase activity increased—Mesalazine—Crohn's disease	0.00105	0.0146	CcSEcCtD
Cefaclor—Vulvovaginal candidiasis—Mesalazine—Crohn's disease	0.00102	0.0142	CcSEcCtD
Cefaclor—Vulvovaginal mycotic infection—Mesalazine—Crohn's disease	0.00098	0.0137	CcSEcCtD
Cefaclor—Candida infection—Mercaptopurine—Crohn's disease	0.000943	0.0132	CcSEcCtD
Cefaclor—Blood potassium increased—Prednisone—Crohn's disease	0.000939	0.0131	CcSEcCtD
Cefaclor—Nephropathy toxic—Mesalazine—Crohn's disease	0.000933	0.013	CcSEcCtD
Cefaclor—Blood lactate dehydrogenase increased—Mesalazine—Crohn's disease	0.000922	0.0129	CcSEcCtD
Cefaclor—Urine analysis abnormal—Mesalazine—Crohn's disease	0.000911	0.0127	CcSEcCtD
Cefaclor—Gastrointestinal symptom NOS—Mesalazine—Crohn's disease	0.000911	0.0127	CcSEcCtD
Cefaclor—Platelet count decreased—Mesalazine—Crohn's disease	0.000901	0.0126	CcSEcCtD
Cefaclor—Thrombocytosis—Mesalazine—Crohn's disease	0.000862	0.012	CcSEcCtD
Cefaclor—Nephritis interstitial—Mesalazine—Crohn's disease	0.000794	0.0111	CcSEcCtD
Cefaclor—Cholestasis—Azathioprine—Crohn's disease	0.000775	0.0108	CcSEcCtD
Cefaclor—Lung disorder—Mesalazine—Crohn's disease	0.000757	0.0106	CcSEcCtD
Cefaclor—MPO—IL23-mediated signaling events—IL17A—Crohn's disease	0.000743	0.0428	CbGpPWpGaD
Cefaclor—Cholestasis—Mesalazine—Crohn's disease	0.000706	0.00985	CcSEcCtD
Cefaclor—Tubulointerstitial nephritis—Mesalazine—Crohn's disease	0.0007	0.00976	CcSEcCtD
Cefaclor—MPO—IL23-mediated signaling events—IL12B—Crohn's disease	0.000691	0.0398	CbGpPWpGaD
Cefaclor—Jaundice cholestatic—Azathioprine—Crohn's disease	0.000669	0.00934	CcSEcCtD
Cefaclor—MPO—Folate Metabolism—GPX4—Crohn's disease	0.000667	0.0384	CbGpPWpGaD
Cefaclor—MPO—lymph node—Crohn's disease	0.00066	0.0132	CbGeAlD
Cefaclor—Gamma-glutamyltransferase increased—Mesalazine—Crohn's disease	0.000651	0.00909	CcSEcCtD
Cefaclor—Jaundice cholestatic—Mesalazine—Crohn's disease	0.00061	0.00851	CcSEcCtD
Cefaclor—Dysmenorrhoea—Mesalazine—Crohn's disease	0.000589	0.00822	CcSEcCtD
Cefaclor—Pancytopenia—Mercaptopurine—Crohn's disease	0.000588	0.00821	CcSEcCtD
Cefaclor—Cough increased—Mesalazine—Crohn's disease	0.000585	0.00817	CcSEcCtD
Cefaclor—Blood bilirubin increased—Mesalazine—Crohn's disease	0.000566	0.00791	CcSEcCtD
Cefaclor—Colitis—Azathioprine—Crohn's disease	0.000565	0.00788	CcSEcCtD
Cefaclor—Aplastic anaemia—Azathioprine—Crohn's disease	0.000552	0.00771	CcSEcCtD
Cefaclor—Neck pain—Mesalazine—Crohn's disease	0.000542	0.00757	CcSEcCtD
Cefaclor—Vaginal inflammation—Mesalazine—Crohn's disease	0.000536	0.00748	CcSEcCtD
Cefaclor—Phosphatase alkaline increased—Mesalazine—Crohn's disease	0.000536	0.00748	CcSEcCtD
Cefaclor—MPO—Selenium Micronutrient Network—GPX4—Crohn's disease	0.00053	0.0305	CbGpPWpGaD
Cefaclor—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.000522	0.00729	CcSEcCtD
Cefaclor—Colitis—Mesalazine—Crohn's disease	0.000514	0.00718	CcSEcCtD
Cefaclor—Candida infection—Mesalazine—Crohn's disease	0.000512	0.00714	CcSEcCtD
Cefaclor—MPO—IL23-mediated signaling events—IL18—Crohn's disease	0.000507	0.0292	CbGpPWpGaD
Cefaclor—Blood urea increased—Mesalazine—Crohn's disease	0.000506	0.00706	CcSEcCtD
Cefaclor—Vaginal infection—Mesalazine—Crohn's disease	0.000506	0.00706	CcSEcCtD
Cefaclor—Aplastic anaemia—Mesalazine—Crohn's disease	0.000503	0.00702	CcSEcCtD
Cefaclor—Hepatic function abnormal—Azathioprine—Crohn's disease	0.000489	0.00682	CcSEcCtD
Cefaclor—Cephaloglycin—SLC22A5—Crohn's disease	0.000471	0.108	CrCbGaD
Cefaclor—Hypertonia—Mesalazine—Crohn's disease	0.00047	0.00655	CcSEcCtD
Cefaclor—SLC15A2—lymph node—Crohn's disease	0.000459	0.00915	CbGeAlD
Cefaclor—Ear pain—Mesalazine—Crohn's disease	0.000456	0.00636	CcSEcCtD
Cefaclor—Immune system disorder—Mercaptopurine—Crohn's disease	0.000448	0.00625	CcSEcCtD
Cefaclor—Blood alkaline phosphatase increased—Mesalazine—Crohn's disease	0.000447	0.00624	CcSEcCtD
Cefaclor—Leukopenia—Mercaptopurine—Crohn's disease	0.000386	0.00539	CcSEcCtD
Cefaclor—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.000385	0.00537	CcSEcCtD
Cefaclor—Face oedema—Mesalazine—Crohn's disease	0.000375	0.00524	CcSEcCtD
Cefaclor—Arthralgia—Mercaptopurine—Crohn's disease	0.000367	0.00513	CcSEcCtD
Cefaclor—Blood creatinine increased—Mesalazine—Crohn's disease	0.000364	0.00509	CcSEcCtD
Cefaclor—Azidocillin—SLC22A5—Crohn's disease	0.000355	0.081	CrCbGaD
Cefaclor—Oedema—Mercaptopurine—Crohn's disease	0.000352	0.00492	CcSEcCtD
Cefaclor—Pancytopenia—Azathioprine—Crohn's disease	0.00035	0.00489	CcSEcCtD
Cefaclor—Cefixime—SLC22A5—Crohn's disease	0.000349	0.0797	CrCbGaD
Cefaclor—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000345	0.00481	CcSEcCtD
Cefaclor—Gastritis—Mesalazine—Crohn's disease	0.000344	0.0048	CcSEcCtD
Cefaclor—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.000343	0.00479	CcSEcCtD
Cefaclor—Asthma—Mesalazine—Crohn's disease	0.000336	0.00469	CcSEcCtD
Cefaclor—Influenza—Mesalazine—Crohn's disease	0.000336	0.00469	CcSEcCtD
Cefaclor—Anorexia—Mercaptopurine—Crohn's disease	0.000336	0.00469	CcSEcCtD
Cefaclor—Eosinophilia—Mesalazine—Crohn's disease	0.000333	0.00465	CcSEcCtD
Cefaclor—Infestation NOS—Azathioprine—Crohn's disease	0.000329	0.00459	CcSEcCtD
Cefaclor—Infestation—Azathioprine—Crohn's disease	0.000329	0.00459	CcSEcCtD
Cefaclor—MPO—Vitamin B12 Metabolism—CRP—Crohn's disease	0.000329	0.0189	CbGpPWpGaD
Cefaclor—Ceftazidime—SLC22A5—Crohn's disease	0.000328	0.0749	CrCbGaD
Cefaclor—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.000326	0.00455	CcSEcCtD
Cefaclor—Cefdinir—SLC22A5—Crohn's disease	0.000322	0.0735	CrCbGaD
Cefaclor—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000321	0.00448	CcSEcCtD
Cefaclor—Pancytopenia—Mesalazine—Crohn's disease	0.000319	0.00446	CcSEcCtD
Cefaclor—MPO—IL23-mediated signaling events—TYK2—Crohn's disease	0.000317	0.0183	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—TAB1—Crohn's disease	0.000316	0.0182	CbGpPWpGaD
Cefaclor—Dysuria—Mesalazine—Crohn's disease	0.000314	0.00439	CcSEcCtD
Cefaclor—Neutropenia—Mesalazine—Crohn's disease	0.000314	0.00439	CcSEcCtD
Cefaclor—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000311	0.00434	CcSEcCtD
Cefaclor—Agranulocytosis—Azathioprine—Crohn's disease	0.000307	0.00429	CcSEcCtD
Cefaclor—Cefradine—SLC22A5—Crohn's disease	0.000306	0.0699	CrCbGaD
Cefaclor—Decreased appetite—Mercaptopurine—Crohn's disease	0.000306	0.00427	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000304	0.00424	CcSEcCtD
Cefaclor—MPO—IL23-mediated signaling events—JAK2—Crohn's disease	0.000303	0.0174	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—ICAM1—Crohn's disease	0.000302	0.0174	CbGpPWpGaD
Cefaclor—Infestation NOS—Mesalazine—Crohn's disease	0.0003	0.00418	CcSEcCtD
Cefaclor—Infestation—Mesalazine—Crohn's disease	0.0003	0.00418	CcSEcCtD
Cefaclor—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000297	0.00415	CcSEcCtD
Cefaclor—MPO—IL23-mediated signaling events—IFNG—Crohn's disease	0.000297	0.0171	CbGpPWpGaD
Cefaclor—Haemoglobin—Azathioprine—Crohn's disease	0.000297	0.00414	CcSEcCtD
Cefaclor—Haemorrhage—Azathioprine—Crohn's disease	0.000295	0.00412	CcSEcCtD
Cefaclor—Conjunctivitis—Mesalazine—Crohn's disease	0.000291	0.00407	CcSEcCtD
Cefaclor—Cefadroxil—SLC22A5—Crohn's disease	0.00029	0.0661	CrCbGaD
Cefaclor—Sweating—Mesalazine—Crohn's disease	0.000287	0.00401	CcSEcCtD
Cefaclor—MPO—IL23-mediated signaling events—CD4—Crohn's disease	0.000287	0.0165	CbGpPWpGaD
Cefaclor—Haematuria—Mesalazine—Crohn's disease	0.000286	0.00399	CcSEcCtD
Cefaclor—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000283	0.00396	CcSEcCtD
Cefaclor—Epistaxis—Mesalazine—Crohn's disease	0.000283	0.00395	CcSEcCtD
Cefaclor—Sinusitis—Mesalazine—Crohn's disease	0.000281	0.00392	CcSEcCtD
Cefaclor—Benzylpenicillin—SLC22A4—Crohn's disease	0.000281	0.0641	CrCbGaD
Cefaclor—Agranulocytosis—Mesalazine—Crohn's disease	0.00028	0.0039	CcSEcCtD
Cefaclor—Erythema multiforme—Azathioprine—Crohn's disease	0.000279	0.0039	CcSEcCtD
Cefaclor—Body temperature increased—Mercaptopurine—Crohn's disease	0.000278	0.00389	CcSEcCtD
Cefaclor—Ampicillin—SLC22A5—Crohn's disease	0.000272	0.062	CrCbGaD
Cefaclor—Haemoglobin—Mesalazine—Crohn's disease	0.00027	0.00377	CcSEcCtD
Cefaclor—Rhinitis—Mesalazine—Crohn's disease	0.00027	0.00376	CcSEcCtD
Cefaclor—Haemorrhage—Mesalazine—Crohn's disease	0.000269	0.00376	CcSEcCtD
Cefaclor—Hepatitis—Mesalazine—Crohn's disease	0.000269	0.00376	CcSEcCtD
Cefaclor—Cefdinir—MPO—Crohn's disease	0.000268	0.061	CrCbGaD
Cefaclor—MPO—Folate Metabolism—CRP—Crohn's disease	0.000267	0.0154	CbGpPWpGaD
Cefaclor—Immune system disorder—Azathioprine—Crohn's disease	0.000267	0.00372	CcSEcCtD
Cefaclor—Urinary tract disorder—Mesalazine—Crohn's disease	0.000266	0.00371	CcSEcCtD
Cefaclor—Oedema peripheral—Mesalazine—Crohn's disease	0.000265	0.0037	CcSEcCtD
Cefaclor—Chills—Azathioprine—Crohn's disease	0.000265	0.0037	CcSEcCtD
Cefaclor—MPO—IL23-mediated signaling events—IL1B—Crohn's disease	0.000265	0.0152	CbGpPWpGaD
Cefaclor—Urethral disorder—Mesalazine—Crohn's disease	0.000264	0.00368	CcSEcCtD
Cefaclor—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00026	0.00362	CcSEcCtD
Cefaclor—Erythema multiforme—Mesalazine—Crohn's disease	0.000254	0.00355	CcSEcCtD
Cefaclor—MPO—Vitamin B12 Metabolism—ALB—Crohn's disease	0.000252	0.0145	CbGpPWpGaD
Cefaclor—Hyperkinesia—Prednisone—Crohn's disease	0.000247	0.00345	CcSEcCtD
Cefaclor—MPO—Folate Metabolism—ICAM1—Crohn's disease	0.000246	0.0141	CbGpPWpGaD
Cefaclor—Immune system disorder—Mesalazine—Crohn's disease	0.000243	0.00339	CcSEcCtD
Cefaclor—Chills—Mesalazine—Crohn's disease	0.000241	0.00337	CcSEcCtD
Cefaclor—Diarrhoea—Mercaptopurine—Crohn's disease	0.000241	0.00336	CcSEcCtD
Cefaclor—Ill-defined disorder—Azathioprine—Crohn's disease	0.000239	0.00333	CcSEcCtD
Cefaclor—Malaise—Azathioprine—Crohn's disease	0.000232	0.00324	CcSEcCtD
Cefaclor—Flatulence—Mesalazine—Crohn's disease	0.000231	0.00322	CcSEcCtD
Cefaclor—Leukopenia—Azathioprine—Crohn's disease	0.00023	0.00321	CcSEcCtD
Cefaclor—Tension—Mesalazine—Crohn's disease	0.00023	0.00321	CcSEcCtD
Cefaclor—MPO—Vitamin B12 Metabolism—IFNG—Crohn's disease	0.00023	0.0132	CbGpPWpGaD
Cefaclor—Nervousness—Mesalazine—Crohn's disease	0.000228	0.00318	CcSEcCtD
Cefaclor—Cardiac failure congestive—Prednisone—Crohn's disease	0.000227	0.00317	CcSEcCtD
Cefaclor—Back pain—Mesalazine—Crohn's disease	0.000227	0.00316	CcSEcCtD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000224	0.0129	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000224	0.0129	CbGpPWpGaD
Cefaclor—Vomiting—Mercaptopurine—Crohn's disease	0.000224	0.00313	CcSEcCtD
Cefaclor—Injury—Prednisone—Crohn's disease	0.000224	0.00312	CcSEcCtD
Cefaclor—MPO—IL23-mediated signaling events—STAT3—Crohn's disease	0.000222	0.0128	CbGpPWpGaD
Cefaclor—Rash—Mercaptopurine—Crohn's disease	0.000222	0.0031	CcSEcCtD
Cefaclor—Dermatitis—Mercaptopurine—Crohn's disease	0.000222	0.0031	CcSEcCtD
Cefaclor—Tremor—Mesalazine—Crohn's disease	0.000219	0.00306	CcSEcCtD
Cefaclor—Myalgia—Azathioprine—Crohn's disease	0.000219	0.00306	CcSEcCtD
Cefaclor—Arthralgia—Azathioprine—Crohn's disease	0.000219	0.00306	CcSEcCtD
Cefaclor—Cefalotin—SLC22A5—Crohn's disease	0.000218	0.0497	CrCbGaD
Cefaclor—Ill-defined disorder—Mesalazine—Crohn's disease	0.000217	0.00303	CcSEcCtD
Cefaclor—Discomfort—Azathioprine—Crohn's disease	0.000216	0.00302	CcSEcCtD
Cefaclor—Angioedema—Mesalazine—Crohn's disease	0.000214	0.00299	CcSEcCtD
Cefaclor—MPO—Selenium Micronutrient Network—CRP—Crohn's disease	0.000212	0.0122	CbGpPWpGaD
Cefaclor—Benzylpenicillin—SLC22A5—Crohn's disease	0.000211	0.0482	CrCbGaD
Cefaclor—Malaise—Mesalazine—Crohn's disease	0.000211	0.00295	CcSEcCtD
Cefaclor—Vertigo—Mesalazine—Crohn's disease	0.00021	0.00294	CcSEcCtD
Cefaclor—Syncope—Mesalazine—Crohn's disease	0.00021	0.00293	CcSEcCtD
Cefaclor—Leukopenia—Mesalazine—Crohn's disease	0.00021	0.00293	CcSEcCtD
Cefaclor—Nausea—Mercaptopurine—Crohn's disease	0.000209	0.00292	CcSEcCtD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000208	0.012	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000208	0.012	CbGpPWpGaD
Cefaclor—Palpitations—Mesalazine—Crohn's disease	0.000207	0.00289	CcSEcCtD
Cefaclor—Loss of consciousness—Mesalazine—Crohn's disease	0.000206	0.00287	CcSEcCtD
Cefaclor—Thrombocytopenia—Azathioprine—Crohn's disease	0.000205	0.00287	CcSEcCtD
Cefaclor—MPO—Vitamin B12 Metabolism—IL1B—Crohn's disease	0.000205	0.0118	CbGpPWpGaD
Cefaclor—MPO—Folate Metabolism—ALB—Crohn's disease	0.000205	0.0118	CbGpPWpGaD
Cefaclor—Cough—Mesalazine—Crohn's disease	0.000204	0.00285	CcSEcCtD
Cefaclor—Myalgia—Mesalazine—Crohn's disease	0.000199	0.00278	CcSEcCtD
Cefaclor—Chest pain—Mesalazine—Crohn's disease	0.000199	0.00278	CcSEcCtD
Cefaclor—Arthralgia—Mesalazine—Crohn's disease	0.000199	0.00278	CcSEcCtD
Cefaclor—Anxiety—Mesalazine—Crohn's disease	0.000199	0.00277	CcSEcCtD
Cefaclor—Face oedema—Prednisone—Crohn's disease	0.000199	0.00277	CcSEcCtD
Cefaclor—Cephalexin—SLC22A5—Crohn's disease	0.000198	0.0452	CrCbGaD
Cefaclor—Discomfort—Mesalazine—Crohn's disease	0.000197	0.00275	CcSEcCtD
Cefaclor—Hypotension—Azathioprine—Crohn's disease	0.000196	0.00274	CcSEcCtD
Cefaclor—MPO—Selenium Micronutrient Network—ICAM1—Crohn's disease	0.000195	0.0112	CbGpPWpGaD
Cefaclor—Confusional state—Mesalazine—Crohn's disease	0.000193	0.00269	CcSEcCtD
Cefaclor—MPO—IL23-mediated signaling events—TNF—Crohn's disease	0.000192	0.0111	CbGpPWpGaD
Cefaclor—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000191	0.00267	CcSEcCtD
Cefaclor—Oedema—Mesalazine—Crohn's disease	0.000191	0.00267	CcSEcCtD
Cefaclor—Anaphylactic shock—Mesalazine—Crohn's disease	0.000191	0.00267	CcSEcCtD
Cefaclor—Shock—Mesalazine—Crohn's disease	0.000188	0.00262	CcSEcCtD
Cefaclor—Nervous system disorder—Mesalazine—Crohn's disease	0.000187	0.00262	CcSEcCtD
Cefaclor—Thrombocytopenia—Mesalazine—Crohn's disease	0.000187	0.00261	CcSEcCtD
Cefaclor—MPO—Folate Metabolism—IFNG—Crohn's disease	0.000187	0.0108	CbGpPWpGaD
Cefaclor—Hyperhidrosis—Mesalazine—Crohn's disease	0.000185	0.00258	CcSEcCtD
Cefaclor—Anorexia—Mesalazine—Crohn's disease	0.000182	0.00254	CcSEcCtD
Cefaclor—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000182	0.00253	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000181	0.00253	CcSEcCtD
Cefaclor—Hypotension—Mesalazine—Crohn's disease	0.000179	0.00249	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000174	0.00243	CcSEcCtD
Cefaclor—Feeling abnormal—Azathioprine—Crohn's disease	0.000173	0.00241	CcSEcCtD
Cefaclor—Insomnia—Mesalazine—Crohn's disease	0.000173	0.00241	CcSEcCtD
Cefaclor—Cefpiramide—ALB—Crohn's disease	0.000173	0.0394	CrCbGaD
Cefaclor—Paraesthesia—Mesalazine—Crohn's disease	0.000172	0.0024	CcSEcCtD
Cefaclor—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000172	0.0024	CcSEcCtD
Cefaclor—Dyspnoea—Mesalazine—Crohn's disease	0.00017	0.00238	CcSEcCtD
Cefaclor—Somnolence—Mesalazine—Crohn's disease	0.00017	0.00237	CcSEcCtD
Cefaclor—Dyspepsia—Mesalazine—Crohn's disease	0.000168	0.00235	CcSEcCtD
Cefaclor—MPO—Folate Metabolism—IL1B—Crohn's disease	0.000167	0.0096	CbGpPWpGaD
Cefaclor—Neutropenia—Prednisone—Crohn's disease	0.000166	0.00232	CcSEcCtD
Cefaclor—Decreased appetite—Mesalazine—Crohn's disease	0.000166	0.00232	CcSEcCtD
Cefaclor—Body temperature increased—Azathioprine—Crohn's disease	0.000166	0.00232	CcSEcCtD
Cefaclor—Abdominal pain—Azathioprine—Crohn's disease	0.000166	0.00232	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000165	0.0023	CcSEcCtD
Cefaclor—Pain—Mesalazine—Crohn's disease	0.000163	0.00228	CcSEcCtD
Cefaclor—Constipation—Mesalazine—Crohn's disease	0.000163	0.00228	CcSEcCtD
Cefaclor—MPO—Selenium Micronutrient Network—ALB—Crohn's disease	0.000163	0.00937	CbGpPWpGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000158	0.00908	CbGpPWpGaD
Cefaclor—Feeling abnormal—Mesalazine—Crohn's disease	0.000158	0.0022	CcSEcCtD
Cefaclor—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000156	0.00218	CcSEcCtD
Cefaclor—MPO—IL23-mediated signaling events—IL6—Crohn's disease	0.000155	0.00893	CbGpPWpGaD
Cefaclor—Hypersensitivity—Azathioprine—Crohn's disease	0.000155	0.00216	CcSEcCtD
Cefaclor—Urticaria—Mesalazine—Crohn's disease	0.000152	0.00212	CcSEcCtD
Cefaclor—Abdominal pain—Mesalazine—Crohn's disease	0.000151	0.00211	CcSEcCtD
Cefaclor—Body temperature increased—Mesalazine—Crohn's disease	0.000151	0.00211	CcSEcCtD
Cefaclor—Cefonicid—ALB—Crohn's disease	0.00015	0.0343	CrCbGaD
Cefaclor—MPO—C-MYB transcription factor network—CD4—Crohn's disease	0.000149	0.00857	CbGpPWpGaD
Cefaclor—MPO—Vitamin B12 Metabolism—TNF—Crohn's disease	0.000149	0.00856	CbGpPWpGaD
Cefaclor—MPO—Selenium Micronutrient Network—IFNG—Crohn's disease	0.000149	0.00855	CbGpPWpGaD
Cefaclor—MPO—C-MYB transcription factor network—PTGS2—Crohn's disease	0.000148	0.00851	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000146	0.00843	CbGpPWpGaD
Cefaclor—Diarrhoea—Azathioprine—Crohn's disease	0.000144	0.002	CcSEcCtD
Cefaclor—Haemoglobin—Prednisone—Crohn's disease	0.000143	0.002	CcSEcCtD
Cefaclor—MPO—Selenium Micronutrient Network—PTGS2—Crohn's disease	0.000142	0.00819	CbGpPWpGaD
Cefaclor—Haemorrhage—Prednisone—Crohn's disease	0.000142	0.00199	CcSEcCtD
Cefaclor—Hallucination—Prednisone—Crohn's disease	0.000142	0.00198	CcSEcCtD
Cefaclor—Hypersensitivity—Mesalazine—Crohn's disease	0.000141	0.00197	CcSEcCtD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000139	0.00803	CbGpPWpGaD
Cefaclor—Dizziness—Azathioprine—Crohn's disease	0.000139	0.00194	CcSEcCtD
Cefaclor—Asthenia—Mesalazine—Crohn's disease	0.000137	0.00191	CcSEcCtD
Cefaclor—Pruritus—Mesalazine—Crohn's disease	0.000135	0.00189	CcSEcCtD
Cefaclor—Vomiting—Azathioprine—Crohn's disease	0.000133	0.00186	CcSEcCtD
Cefaclor—MPO—Selenium Micronutrient Network—IL1B—Crohn's disease	0.000132	0.00762	CbGpPWpGaD
Cefaclor—Rash—Azathioprine—Crohn's disease	0.000132	0.00185	CcSEcCtD
Cefaclor—Dermatitis—Azathioprine—Crohn's disease	0.000132	0.00185	CcSEcCtD
Cefaclor—Headache—Azathioprine—Crohn's disease	0.000131	0.00183	CcSEcCtD
Cefaclor—Diarrhoea—Mesalazine—Crohn's disease	0.000131	0.00183	CcSEcCtD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000129	0.00745	CbGpPWpGaD
Cefaclor—Immune system disorder—Prednisone—Crohn's disease	0.000129	0.00179	CcSEcCtD
Cefaclor—Dizziness—Mesalazine—Crohn's disease	0.000126	0.00176	CcSEcCtD
Cefaclor—Nausea—Azathioprine—Crohn's disease	0.000125	0.00174	CcSEcCtD
Cefaclor—Vomiting—Mesalazine—Crohn's disease	0.000122	0.0017	CcSEcCtD
Cefaclor—MPO—Folate Metabolism—TNF—Crohn's disease	0.000121	0.00696	CbGpPWpGaD
Cefaclor—Rash—Mesalazine—Crohn's disease	0.000121	0.00168	CcSEcCtD
Cefaclor—Dermatitis—Mesalazine—Crohn's disease	0.00012	0.00168	CcSEcCtD
Cefaclor—MPO—Vitamin B12 Metabolism—IL6—Crohn's disease	0.00012	0.00691	CbGpPWpGaD
Cefaclor—Headache—Mesalazine—Crohn's disease	0.00012	0.00167	CcSEcCtD
Cefaclor—Ill-defined disorder—Prednisone—Crohn's disease	0.000115	0.0016	CcSEcCtD
Cefaclor—Agitation—Prednisone—Crohn's disease	0.000114	0.00159	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000114	0.00655	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000114	0.00655	CbGpPWpGaD
Cefaclor—Nausea—Mesalazine—Crohn's disease	0.000114	0.00158	CcSEcCtD
Cefaclor—Angioedema—Prednisone—Crohn's disease	0.000113	0.00158	CcSEcCtD
Cefaclor—Malaise—Prednisone—Crohn's disease	0.000112	0.00156	CcSEcCtD
Cefaclor—Vertigo—Prednisone—Crohn's disease	0.000111	0.00155	CcSEcCtD
Cefaclor—Syncope—Prednisone—Crohn's disease	0.000111	0.00155	CcSEcCtD
Cefaclor—Loss of consciousness—Prednisone—Crohn's disease	0.000109	0.00152	CcSEcCtD
Cefaclor—Convulsion—Prednisone—Crohn's disease	0.000107	0.0015	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000106	0.00608	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000106	0.00608	CbGpPWpGaD
Cefaclor—Myalgia—Prednisone—Crohn's disease	0.000106	0.00147	CcSEcCtD
Cefaclor—Arthralgia—Prednisone—Crohn's disease	0.000106	0.00147	CcSEcCtD
Cefaclor—Anxiety—Prednisone—Crohn's disease	0.000105	0.00147	CcSEcCtD
Cefaclor—Discomfort—Prednisone—Crohn's disease	0.000104	0.00145	CcSEcCtD
Cefaclor—Oedema—Prednisone—Crohn's disease	0.000101	0.00141	CcSEcCtD
Cefaclor—Anaphylactic shock—Prednisone—Crohn's disease	0.000101	0.00141	CcSEcCtD
Cefaclor—Shock—Prednisone—Crohn's disease	9.95e-05	0.00139	CcSEcCtD
Cefaclor—Nervous system disorder—Prednisone—Crohn's disease	9.92e-05	0.00138	CcSEcCtD
Cefaclor—Hyperhidrosis—Prednisone—Crohn's disease	9.78e-05	0.00136	CcSEcCtD
Cefaclor—MPO—Folate Metabolism—IL6—Crohn's disease	9.77e-05	0.00562	CbGpPWpGaD
Cefaclor—Anorexia—Prednisone—Crohn's disease	9.64e-05	0.00135	CcSEcCtD
Cefaclor—MPO—Selenium Micronutrient Network—TNF—Crohn's disease	9.61e-05	0.00553	CbGpPWpGaD
Cefaclor—Musculoskeletal discomfort—Prednisone—Crohn's disease	9.22e-05	0.00129	CcSEcCtD
Cefaclor—Insomnia—Prednisone—Crohn's disease	9.15e-05	0.00128	CcSEcCtD
Cefaclor—Paraesthesia—Prednisone—Crohn's disease	9.08e-05	0.00127	CcSEcCtD
Cefaclor—Dyspepsia—Prednisone—Crohn's disease	8.9e-05	0.00124	CcSEcCtD
Cefaclor—Decreased appetite—Prednisone—Crohn's disease	8.79e-05	0.00123	CcSEcCtD
Cefaclor—Constipation—Prednisone—Crohn's disease	8.65e-05	0.00121	CcSEcCtD
Cefaclor—Feeling abnormal—Prednisone—Crohn's disease	8.33e-05	0.00116	CcSEcCtD
Cefaclor—Gastrointestinal pain—Prednisone—Crohn's disease	8.27e-05	0.00115	CcSEcCtD
Cefaclor—Urticaria—Prednisone—Crohn's disease	8.04e-05	0.00112	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—GCKR—Crohn's disease	8.02e-05	0.00461	CbGpPWpGaD
Cefaclor—Body temperature increased—Prednisone—Crohn's disease	8e-05	0.00112	CcSEcCtD
Cefaclor—Abdominal pain—Prednisone—Crohn's disease	8e-05	0.00112	CcSEcCtD
Cefaclor—MPO—Selenium Micronutrient Network—IL6—Crohn's disease	7.76e-05	0.00446	CbGpPWpGaD
Cefaclor—Ampicillin—ALB—Crohn's disease	7.53e-05	0.0172	CrCbGaD
Cefaclor—Hypersensitivity—Prednisone—Crohn's disease	7.45e-05	0.00104	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	7.44e-05	0.00428	CbGpPWpGaD
Cefaclor—Asthenia—Prednisone—Crohn's disease	7.26e-05	0.00101	CcSEcCtD
Cefaclor—Pruritus—Prednisone—Crohn's disease	7.16e-05	0.000999	CcSEcCtD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	7.09e-05	0.00408	CbGpPWpGaD
Cefaclor—Diarrhoea—Prednisone—Crohn's disease	6.92e-05	0.000966	CcSEcCtD
Cefaclor—Dizziness—Prednisone—Crohn's disease	6.69e-05	0.000933	CcSEcCtD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	6.58e-05	0.00379	CbGpPWpGaD
Cefaclor—Vomiting—Prednisone—Crohn's disease	6.43e-05	0.000897	CcSEcCtD
Cefaclor—Rash—Prednisone—Crohn's disease	6.38e-05	0.00089	CcSEcCtD
Cefaclor—Dermatitis—Prednisone—Crohn's disease	6.37e-05	0.000889	CcSEcCtD
Cefaclor—Headache—Prednisone—Crohn's disease	6.34e-05	0.000884	CcSEcCtD
Cefaclor—Cefalotin—ALB—Crohn's disease	6.04e-05	0.0138	CrCbGaD
Cefaclor—Nausea—Prednisone—Crohn's disease	6.01e-05	0.000838	CcSEcCtD
Cefaclor—Cephalexin—ALB—Crohn's disease	5.49e-05	0.0125	CrCbGaD
Cefaclor—SLC15A2—SLC-mediated transmembrane transport—ALB—Crohn's disease	5.02e-05	0.00289	CbGpPWpGaD
Cefaclor—SLC15A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	4.66e-05	0.00268	CbGpPWpGaD
Cefaclor—SLC15A2—Transmembrane transport of small molecules—ALB—Crohn's disease	2.55e-05	0.00147	CbGpPWpGaD
Cefaclor—SLC15A1—Transmembrane transport of small molecules—ALB—Crohn's disease	2.37e-05	0.00136	CbGpPWpGaD
